Palisade Bio (PALI) EBITDA Margin (QoQ) (2011 - 2020)
Palisade Bio (PALI) EBITDA Margin (QoQ) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5.72 Mn |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | -4.06 Mn |
| Mar 31, 2020 | 5.22 Mn |
| Dec 31, 2019 | -33,592.00 |
| Sep 30, 2019 | -6.07 Mn |
| Jun 30, 2019 | 7.40 Mn |
| Mar 31, 2019 | -2.61 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | -8.25 Mn |
| Jun 30, 2018 | 9.32 Mn |
| Mar 31, 2018 | -9.31 Mn |
| Dec 31, 2017 | 10.26 Mn |
| Sep 30, 2017 | 6.52 Mn |
| Jun 30, 2017 | 55,104.00 |
| Mar 31, 2017 | -10.47 Mn |
| Dec 31, 2016 | 13.21 Mn |
| Sep 30, 2016 | -4.33 Mn |
| Jun 30, 2016 | 9.60 Mn |
| Mar 31, 2016 | -7.53 Mn |